... cholesterol ratio HDL cholesterol mild essential hypertension oxprenolol β-receptor blockade triglycerides Clinical Science (1982) 6 3 , 4 6 3 ~ 4 6 5 ~ 463s Effect on high density lipoprotein cholesterol of atenolol and oxprenolol in patients with mild essential hypertension S. E . K J E L D S E N...

... Society 1981 chlorthalidone clopamide diuretics lipoproteins pindolol propranolol β-receptor blockade Clinical Science (1981) 61,437~439s 437s P-Receptor-blocking agents may reverse or prevent diuretic-induced increases in serum low-density lipoprotein cholesterol A. M E I E R , H . S C H I...

... Society 1980 antihypertensive therapy β-receptor blockade vasodilators Clinical Science (1980) 59 ,461~463s 461s Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a P-receptor-blocking and vasodilating compound G . L E O N E T T I , L A U R A T E R Z O L I , C...

... Research Society 1976 atenolol bendrofluazide hypertension plasma renin concentration β-receptor blockade Clinical Science and Molecular Medicine (1976) 51, 21 59-21 7s. Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol R . F A G A R D , A. A M E R Y , J...

... agents unsupported by β-receptor blockade. hypertension myocardial infarction β-receptor blockade © 1976 The Biochemical Society and the Medical Research Society 1976 Clinical Science and Molecular Medicine (1976) 51, 509~-511s. Compared incidence of first myocardial infarction...

... and 4 h, except for sotalol (10–12 h). Plasma elimination of propranolol is reduced with decreased liver blood flow, observed in congestive heart failure or during chronic propranolol therapy itself. 3. β-Receptor blockade is usually achieved in these concentration ranges: propranolol and alprenolol, 50...

... differences exist with respect to effect upon stroke volume and total peripheral resistance. © 1976 The Biochemical Society and the Medical Research Society 1976 alprenolol atenolol exercise haemodynamics hypertension metoprolol β-receptor blockade timolol Clinical Science and Molecular...

... no significant differences between blood pressure at the beginning and end of the 12 weeks period. 3. Once-daily dosage offers advantages of patient compliance. © 1976 The Biochemical Society and the Medical Research Society 1976 hypertension β-receptor blockade slow-release oxprenolol Clinical...